Robert A. Michael
Chairman Of The Board And Chief Executive Officer
AbbVie Inc. · ABBV
$32.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 23, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.7M
- Stock Awards
- $13.3M
- Option Awards
- $3.2M
- Incentives
- $5.2M
- Other
- $9.2M
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,700,000 | $13,268,456 | $32,530,984 |
| 2024 | $1,607,404 | $7,915,762 | $18,492,517 |
| 2023 | $1,427,376 | $5,440,297 | $14,441,320 |
Current Position
- Company
- AbbVie Inc.
- Title
- Chairman Of The Board And Chief Executive Officer
- Ticker
- ABBV · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 23, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001104659-26-033387.
Other AbbVie Executives
Scott T. Reents
Executive Vice President, Chief Financial Officer
AbbVie · ABBV
$12.4M
FY 2025 · DEF 14A
Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
AbbVie · ABBV
$15.4M
FY 2025 · DEF 14A
Azita Saleki-Gerhardt
Executive Vice President, Chief Operations Officer
AbbVie · ABBV
$10.8M
FY 2025 · DEF 14A
Roopal B. Thakkar
Executive Vice President, Chief Scientific Officer
AbbVie · ABBV
$9.9M
FY 2025 · DEF 14A